Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial

Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial

Attempts to develop a drug treatment for female sexual interest/arousal disorder have so far been guided by the principle of ‘one size fits all’, and have failed to acknowledge the complexity of female sexuality. Guided by personalized medicine, we designed two on-demand drugs targeting two distinct...

Full description

Bibliographic Details
Main Authors: Adriaan Tuiten, Frits Michiels, Koen BE Böcker, Daniël Höhle, Jack van Honk, Robert PJ de Lange, Kim van Rooij, Rob Kessels, Jos Bloemers, Jeroen Gerritsen, Paddy Janssen, Leo de Leede, John-Jules Meyer, Walter Everaerd, Henderik W Frijlink, Hans PF Koppeschaar, Berend Olivier, James G Pfaus
Format: Article
Language:English
Published: SAGE Publishing 2018-07-01
Series:Women's Health
Online Access:https://doi.org/10.1177/1745506518788970

Internet

https://doi.org/10.1177/1745506518788970

Similar Items